Cite
HARVARD Citation
Monge, C. et al. (n.d.). A phase I/II study of JX-594 oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer. European journal of cancer. pp. S57-S58. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Monge, C. et al. (n.d.). A phase I/II study of JX-594 oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer. European journal of cancer. pp. S57-S58. [Online].